annual SGA:
$37.93M+$6.85M(+22.06%)Summary
- As of today (June 29, 2025), AKRO annual SGA is $37.93 million, with the most recent change of +$6.85 million (+22.06%) on December 31, 2024.
- During the last 3 years, AKRO annual SGA has risen by +$18.80 million (+98.29%).
- AKRO annual SGA is now at all-time high.
Performance
AKRO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$11.31M+$2.58M(+29.58%)Summary
- As of today (June 29, 2025), AKRO quarterly SGA is $11.31 million, with the most recent change of +$2.58 million (+29.58%) on March 31, 2025.
- Over the past year, AKRO quarterly SGA has increased by +$2.01 million (+21.61%).
- AKRO quarterly SGA is now at all-time high.
Performance
AKRO quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$3.16B-$269.44M(-9.31%)Summary
- As of today (June 29, 2025), AKRO TTM SGA is -$3.16 billion, with the most recent change of -$269.44 million (-9.31%) on March 31, 2025.
- Over the past year, AKRO TTM SGA has dropped by -$3.20 billion (-9566.02%).
- AKRO TTM SGA is now -3553.43% below its all-time high of -$86.56 million.
Performance
AKRO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
AKRO Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.1% | +21.6% | -9566.0% |
| 3 y3 years | +98.3% | +104.3% | -10000.0% |
| 5 y5 years | +340.7% | +215.4% | -10000.0% |
AKRO Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +98.3% | at high | +104.3% | -168.5% | at low |
| 5 y | 5-year | at high | +340.7% | at high | +231.1% | -550.2% | at low |
| alltime | all time | at high | +1900.3% | at high | +5702.6% | -3553.4% | at low |
AKRO Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $11.31M(+29.6%) | $39.94M(+5.3%) |
| Dec 2024 | $37.93M(+22.1%) | $8.73M(-7.8%) | $37.93M(+0.7%) |
| Sep 2024 | - | $9.47M(-9.1%) | $37.67M(+4.1%) |
| Jun 2024 | - | $10.42M(+12.0%) | $36.19M(+8.3%) |
| Mar 2024 | - | $9.30M(+9.7%) | $33.41M(+7.5%) |
| Dec 2023 | $31.07M(+4.0%) | $8.48M(+6.3%) | $31.07M(+4.7%) |
| Sep 2023 | - | $7.98M(+4.4%) | $29.69M(-9.2%) |
| Jun 2023 | - | $7.64M(+9.7%) | $32.71M(+4.5%) |
| Mar 2023 | - | $6.97M(-1.9%) | $31.30M(+4.8%) |
| Dec 2022 | $29.87M(+56.2%) | $7.10M(-35.5%) | $29.87M(+8.6%) |
| Sep 2022 | - | $11.00M(+76.6%) | $27.50M(+28.6%) |
| Jun 2022 | - | $6.23M(+12.5%) | $21.38M(+6.2%) |
| Mar 2022 | - | $5.54M(+17.1%) | $20.14M(+5.3%) |
| Dec 2021 | $19.13M | $4.73M(-3.2%) | $19.13M(+3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $4.88M(-2.1%) | $18.47M(+4.1%) |
| Jun 2021 | - | $4.99M(+10.3%) | $17.75M(+9.7%) |
| Mar 2021 | - | $4.53M(+11.1%) | $16.18M(+6.2%) |
| Dec 2020 | $15.24M(+77.1%) | $4.07M(-2.0%) | $15.24M(+7.0%) |
| Sep 2020 | - | $4.16M(+21.7%) | $14.25M(+13.9%) |
| Jun 2020 | - | $3.42M(-4.8%) | $12.51M(+16.5%) |
| Mar 2020 | - | $3.59M(+16.4%) | $10.74M(+24.9%) |
| Dec 2019 | $8.61M(+353.9%) | $3.08M(+27.2%) | $8.61M(+32.2%) |
| Sep 2019 | - | $2.42M(+47.0%) | $6.51M(+42.8%) |
| Jun 2019 | - | $1.65M(+13.8%) | $4.56M(+44.7%) |
| Mar 2019 | - | $1.45M(+47.1%) | $3.15M(+66.1%) |
| Dec 2018 | $1.90M | $985.00K(+107.8%) | $1.90M(+108.1%) |
| Sep 2018 | - | $474.00K(+95.9%) | $911.00K(+108.5%) |
| Jun 2018 | - | $242.00K(+24.1%) | $437.00K(+124.1%) |
| Mar 2018 | - | $195.00K | $195.00K |
FAQ
- What is Akero Therapeutics annual SGA?
- What is the all time high annual SGA for Akero Therapeutics?
- What is Akero Therapeutics annual SGA year-on-year change?
- What is Akero Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Akero Therapeutics?
- What is Akero Therapeutics quarterly SGA year-on-year change?
- What is Akero Therapeutics TTM SGA?
- What is the all time high TTM SGA for Akero Therapeutics?
- What is Akero Therapeutics TTM SGA year-on-year change?
What is Akero Therapeutics annual SGA?
The current annual SGA of AKRO is $37.93M
What is the all time high annual SGA for Akero Therapeutics?
Akero Therapeutics all-time high annual SGA is $37.93M
What is Akero Therapeutics annual SGA year-on-year change?
Over the past year, AKRO annual SGA has changed by +$6.85M (+22.06%)
What is Akero Therapeutics quarterly SGA?
The current quarterly SGA of AKRO is $11.31M
What is the all time high quarterly SGA for Akero Therapeutics?
Akero Therapeutics all-time high quarterly SGA is $11.31M
What is Akero Therapeutics quarterly SGA year-on-year change?
Over the past year, AKRO quarterly SGA has changed by +$2.01M (+21.61%)
What is Akero Therapeutics TTM SGA?
The current TTM SGA of AKRO is -$3.16B
What is the all time high TTM SGA for Akero Therapeutics?
Akero Therapeutics all-time high TTM SGA is -$86.56M
What is Akero Therapeutics TTM SGA year-on-year change?
Over the past year, AKRO TTM SGA has changed by -$3.20B (-9566.02%)